# Medplus Health Services Limited (MEDPLUS)

> MEDPLUS closed at ₹579.90 on 30 Oct 2026, trailing P/E 33.0, market cap ₹6,967 cr, latest results for the quarter ended 30 Sept 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Medplus Health Services Limited (NSE: MEDPLUS) closed at ₹579.90 on 30 Oct 2026, -24.0% over one year, against a 52-week range of ₹565.60 – ₹1,022.20.

In the quarter ended 30 Sept 2026 (consolidated, filed 27 Oct 2026) it reported revenue of ₹2,037 cr and net profit of ₹56 cr, a 2.8% net margin; revenue grew 21.3% and profit grew 1.8% year on year.

On four consecutive filed quarters its trailing P/E is 33.0; since 27 May 2025 its own P/E has ranged from 32.9 to 77.3 (median 52.0), and today's reading is higher than 0% of those 353 trading days.

From the balance sheet dated 30 Sept 2026: return on equity 10.8%, ROCE 12.5%, debt-to-equity 0.00, Piotroski F-score 7 of 9.

Against 40 Consumer Services peers on NSE: Net margin higher than 30% of 40 sector peers; PBT margin higher than 28% of 40 sector peers; ROE higher than 58% of 40 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹579.90 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -11.4% / -35.8% / -24.0% |
| 52-week low – high | ₹565.60 – ₹1,022.20 |
| Market capitalisation | ₹6,967 cr |
| Trailing P/E | 33.0 |
| Price / book | 3.37 |
| EV / EBITDA | 9.6 |
| Earnings yield | 3.0% |
| TTM EPS | ₹17.57 |
| TTM net profit | ₹211 cr |
| Quarter revenue | ₹2,037 cr |
| Quarter net profit | ₹56 cr |
| Net margin | 2.8% |
| Revenue growth (YoY) | +21.3% |
| Profit growth (YoY) | +1.8% |
| Return on equity | 10.8% |
| ROCE | 12.5% |
| Debt / equity | 0.00 |
| Current ratio | 2.83 |
| Free cash flow | ₹85 cr |
| Piotroski F-score | 7 / 9 |
| Average daily turnover (50 days) | ₹5.8 cr |

## Questions

### What is the P/E ratio of Medplus Health Services Limited?

Medplus Health Services Limited's trailing P/E is 33.0, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 27 May 2025 its P/E has ranged 32.9–77.3.

### What were Medplus Health Services Limited's latest quarterly results?

For the quarter ended 30 Sept 2026, Medplus Health Services Limited reported revenue of ₹2,037 cr and net profit of ₹56 cr (consolidated), filed with the exchange on 27 Oct 2026.

### What is Medplus Health Services Limited's ROE?

Return on equity is 10.8% based on the balance sheet dated 30 Sept 2026.

### Does Medplus Health Services Limited have debt?

Debt-to-equity is 0.00 on the balance sheet dated 30 Sept 2026.

### What is MEDPLUS's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, MEDPLUS traded between ₹565.60 and ₹1,022.20.

Sector: [Consumer Services](https://trinetra.trade/sectors/consumer-services) · Page: https://trinetra.trade/fundamentals/MEDPLUS

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._